4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-015319
Corporate Controller & CAO sold 635 shares at $57.22 ($36,335)
- Corporate Controller & CAO acquired 1,807 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| German Christopher Paul Corporate Controller & CAO | 2025-02-16 | Option exercise | +1,807 | 2,705 | D | ||
| German Christopher Paul Corporate Controller & CAO | 2025-02-19 | Sale | −635 | $57.22 | $36,335 | 2,070 | D |
| Derivatives | |||||||
| German Christopher Paul Corporate Controller & CAO | 2025-02-14 | Grant or award · Restricted Stock Units | +7,225 | 7,225 | D | ||
| German Christopher Paul Corporate Controller & CAO | 2025-02-14 | Grant or award · Stock Options (Right to Buy) | +5,400 | 5,400 | D | ||
| German Christopher Paul Corporate Controller & CAO | 2025-02-16 | Option exercise · Restricted Stock Units | −1,807 | 5,418 | D | ||
| Open-market sales · 635 sh · avg $57.22 · $36,335 | |||||||
Loading xslF345X05/tm257103-3_4seq1.xml…